Salesforce Stock Downgraded at 'possibly Exactly the Wrong Time'

Dow Jones
07/09

"It's possible we're downgrading Salesforce at exactly the wrong time," KeyBanc analysts wrote as they bumped the software stock anyway.

It's the conundrum facing Salesforce and software investors right now. Salesforce has fallen 37% this year and the iShares Expanded Tech-Software Sector ETF is down 13% amid fears about the disruption caused by artificial intelligence.

More than 70% of analysts covering Salesforce stock think it's a Buy, with an average price target of $241.08, implying a 45% jump from Wednesday's closing price of $166.58.

But what if everyone is waiting for a rebound that's never going to come?

KeyBanc's Jackson Ader acknowledged that downgrading the stock to Sector Weight from Overweight late Wednesday may end up being poor timing. "But at some point, we have to ask ourselves, why gather the evidence if we're not going to use it," he added.

The firm's checks and conversations with customers have "not been strong, " and neither has the feedback on Agentforce--the company's AI agent offering.

"What we can piece together in the disclosed numbers does not signal building momentum," Ader said, lowering estimates, downgrading the stock to Sector Weight from Overweight, and removing his price target altogether.

It's another blow for the stock, which was down 3.8% in premarket trading Thursday.

Barron's dropped its own Buy recommendation on the stock last month. The company hasn't done enough to dispel the market's concern that its days of high growth are behind it, Barron's argued.

Write to Callum Keown at callum.keown@dowjones.com

This content was created by Barron's, which is operated by Dow Jones & Co. Barron's is published independently from Dow Jones Newswires and The Wall Street Journal.

 

(END) Dow Jones Newswires

July 09, 2026 07:42 ET (11:42 GMT)

Copyright (c) 2026 Dow Jones & Company, Inc.

应版权方要求,你需要登录查看该内容

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10